A Study for the Transdermal Application of Teriparatide
Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to help answer the following research questions:
1. How teriparatide given using a skin patch (transferred through the skin using the
ViaDerm Teriparatide System) compares to teriparatide injected under the skin with a
needle (pen injector) affects your bone density (how solid or porous your bones are).
2. The safety of the teriparatide skin patch and any side effects that might be associated
with it.